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A B S T R A C T   
Human induced pluripotent stem cell (iPSC) lines have been derived from four male patients with childhood attention-deficit hyperactivity disorder (ADHD). 
Children and adolescents between the ages 6 and 18 suffering from ADHD were recruited for this work. Isolated keratinocytes or peripheral blood mononuclear cells 
from the participants were reprogrammed into iPSCs using non-integrating Sendai virus to deliver the reprogramming factors Oct3/4, Sox2, Klf4 and c-Myc.   
Resource Table:  









Alternative names of stem 
cell lines 
MR001 c3 (TMPi006-A) 
MR001 c15 (TMPi006-B) 
MR010 c3 (TMPi007-A) 
MR010 c18 (TMPi007-B) 
MR013 c3 (TMPi008-A) 
MR014 c12.1.1 (TMPi009-A) 
MR014 c27 (TMPi009-B) 
Institution Psychiatric University Hospital Zurich, Department of 
Child and Adolescent Psychiatry and Psychotherapy, 
University of Zurich 
Contact information of 
distributor 
Prof. Dr. Edna Grünblatt (edna.gruenblatt@kjpd.uzh. 
ch) 
Type of cell lines iPSC 
Origin Human 
Cell Source Keratinocytes and peripheral blood mononuclear cells 
Clonality Clonal 
Method of reprogramming Sendai virus 
Multiline rationale Control and disease pair (Yde Ohki et al., 2021) 
Gene modification NO 
(continued on next column)  
(continued ) 
Type of modification N/A 
Associated disease Attention-Deficit Hyperactivity Disorder (ADHD) 
Gene/locus N/A 
Method of modification N/A 






Date archived/stock date March 2020 
Cell line repository/bank N/A 
Ethical approval Cantonal Ethics Committee (BASEC-Nr.-2016–00101 & 
BASEC-Nr.-201700825)   
1. Resource utility 
iPSC lines derived from patients with ADHD are a useful tool to 
create a model of the disorder. Characterized iPSCs and derived 
neuronal stem cells or neurons from patients can be compared to healthy 
control lines to study various molecular pathways and thereby fill the 
gap of knowledge behind the cellular and molecular origin of ADHD. 
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2. Resource details 
ADHD is a heterogeneous childhood developmental disorder with a 
high prevalence of 5% in children and adolescents (American Psychi-
atric Association, 2013). In the present study, seven iPSC lines were 
established from four ADHD patients using a Sendai virus reprogram-
ming kit (Invitrogen – Thermo Fisher Scientific) to deliver the four 
Yamanaka reprogramming factors. 
Keratinocytes and peripheral blood mononuclear cells (PBMCs) from 
ADHD patients were reprogrammed into seven different iPSC lines using 
Sendai virus (Table 1). The characterization of the derived iPSC lines is 
summarized in Table 2. All derived clones displayed typical iPSC 
morphology: The border of the colonies was well defined and the col-
onies themselves were composed of small cells with prominent nuclei 
(Fig. 1A, LM: light microscopy, scale bar: 200 µm). The expression of key 
pluripotency markers OCT4, SSEA4, TRA-1-60 and SOX2 was confirmed 
in all cell lines by immunocytochemistry proofing their pluripotent 
potential (Fig. 1A, scale bar: 200 µm). All cell lines were tested for 
mycoplasma contamination. PCR products generated with a myco-
plasma detection kit were run on a 1.2% agarose gel (Fig. 1B). The 
negative internal control sample showed a distinct control band at 480 
base pair indicating a successful PCR reaction. The positive control 
showed a band at 260 base pair. No mycoplasma contamination was 
detected. The cell lines had a normal karyotype without any gross 
genomic aberrations (Fig. 1C represents MR001 c3, see all lines in 
Supplementary). Sendai virus trace testing was performed using quan-
titative real-time PCR (qRT-PCR). The positive control, P1 iPSC, showed 
high expression of SeV (relative expression = 100%) and the negative 
control, control iPSC, no expression (Fig. 1D). Minimal residues of 
Sendai virus (relative expression = 0.44%) were detected in cell line 
MR001 c3 (Fig. 1D). In addition to immunocytochemistry, qRT-PCR was 
used to reveal the pluripotency potential of the cells. The activation of 
pluripotent genes such as NANOG, OCT4, LIN28A and SOX2 was 
confirmed in all cell lines (Fig. 1E). The formation of embryoid bodies 
(EBs) assessed the differentiation potential of the iPSC lines (Fig. 1A, LM: 
light microscopy, scale bar: 200 µm). The formation of all three germ 
layers was confirmed by the expression of endodermal, mesodermal and 
ectodermal markers using qRT-PCR (Fig. 1F). 
3. Materials and methods 
3.1. Subject recruitment 
Four male children and adolescents with ADHD were recruited by 
experienced clinicians of the Department of Child and Adolescent Psy-
chiatry and Psychotherapy, University Hospital of Psychiatry Zurich. 
ADHD of the patients fulfilled the criteria according to DSM-5 as well as 
ICD-10 (World Health Organization, 1992; American Psychiatric Asso-
ciation, 2013). Standardized clinical interviews have been performed 
and subjects suffering from a severe psychiatric or neurological 
comorbidities were excluded to accomplish the utmost homogeneity of 
the ADHD core symptoms (see Supplementary). Furthermore, the ge-
netic background of each participant was analysed using a polygenic risk 
score (PRS) analysis. The PRS, a weighted sum of the number of risk 
alleles a patient carries for a specific disease, was calculated to assess the 
genetic load using the most recent meta-analysis identifying the first 
genome-wide significant loci for ADHD association study (GWAS) by 
Demontis et al. (2019). 
3.2. Reprogramming 
iPSCs were generated from either patient derived keratinocytes or 
PBMCs using a Sendai virus CytoTuneTM-iPS 2.0 kit (Invitrogen – 
Thermo Fisher Scientific) carrying three non-integrative viral vectors 
containing polycistronic Klf4-Oct3/4-Sox2 (KOS), c-Myc and Klf4. Ker-
atinocyte culture and reprogramming was initiated three days prior to 
viral transduction and the reprogramming was performed in accordance 
with a previously established protocol (Re et al., 2018). PBMC culture 
and reprogramming was initiated four days before viral transduction. 
Table 2 
Characterization and validation.  
Classification Test Result Data 
Morphology Photography Normal Fig. 1 panel A 
















Fig. 1 panel E 
Genotype Genetic integrity analysis 
comparing saliva and 
iPSC DNA CNVs using 
genome-wide association 
array 
All lines: 46, 
XY 
Fig. 1 panel C 
and  
Supplementary 










Sequencing N/A N/A 
Southern Blot OR WGS N/A N/A 
Microbiology 
and virology 
Mycoplasma Negative Fig. 1 panel B 
Differentiation 
potential 





















Saliva genotyping DNA analysis Not shown but 
available with 
author 
HLA tissue typing N/A N/A  
Table 1 
Summary of lines.  
iPSC line names Abbreviation in figures Gender Age Ethnicity Genotype of locus Disease Primary material 
TMPi006-A MR001 c3 Male 15 Caucasian N/A ADHD Keratinocytes 
TMPi006-B MR001 c15 Male 15 Caucasian N/A ADHD Keratinocytes 
TMPi007-A MR010 c3 Male 9 Caucasian N/A ADHD Keratinocytes 
TMPi007-B MR010 c18 Male 9 Caucasian N/A ADHD Keratinocytes 
TMPi008-A MR013 c3 Male 16 Caucasian N/A ADHD PBMCs 
TMPi009-A MR014 c12.1.1 Male 13 Caucasian N/A ADHD PBMCs 
TMPi009-B MR014 c27 Male 13 Caucasian N/A ADHD PBMCs  
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The reprogramming was performed according to manufacturer’s in-
structions. Derived iPSCs were cultured under serum- and feeder-free 
conditions on Vitronectin (Gibco) in E8 medium supplemented with 
10 mM Y-27362 (StemcellTM). The iPSCs were passaged every three to 
four days in a 1:3 splitting ratio using Versene Solution (Gibco). Quality 
control was performed on all cell lines after reaching passage 11. 
3.3. Embryoid body formation 
iPSCs were cultured in AggreWells with E8/PVA medium for two 
days to form EBs according to a protocol by Lin and Chen (2014). 
3.4. Immunocytochemistry 
Expression of SSEA4, OCT4, SOX2 and TRA-1-60 in iPSCs was 
assessed with the Pluripotent Stem Cell 4-Marker Immunocytochemistry 
Kit (Invitrogen™) following manufacturer’s instructions (Table 3). 
3.5. Real-time quantitative PCR analysis 
RNA was extracted from iPSCs using the RNeasy® Plus Mini kit 
(Qiagen) according to manufacturer’s instructions. 500 ng RNA per iPSC 
sample, respectively 1 µg RNA per EB sample, were reverse transcribed 
into cDNA using the iScript™ cDNA Synthesis Kit (Bio-Rad) with a 
C1000™/CFX96™ thermal cycler. Gene expression profiles were 
assessed using the QuantiFast® SYBR® Green PCR kit (Qiagen). Each 
sample was run in triplicates. Genes of interest (GOI) and reference 
genes (RG) were amplified on the CFX384 thermal cycler using the 
primers detailed in Table 3. LinRegPCR (version 2020.0.0.3) was used to 
calculate the PCR efficiency and Biogazelle qBasePLUS2 (version 2.3) to 
normalize the mRNA levels of GOI against the RGs (ACTB and HMBS for 
iPSCs, ACTB and GAPDH for EBs). A heatmap plot was generated in 
RStudio (version 1.1.423) with the package heatmap3. 
3.6. Detection of SeV genome 
iPSC lines were tested for Sendai virus residues by qRT-PCR, as 
described above, using a primer for SeV amplification (Table 3). RNA 
from a passage one iPSC was used as positive control. Negative control 
RNA was obtained from a commercial human episomal iPSC line 
(A18945, Thermo Fisher Scientific, derived from CD34 + cord blood 
using a three-plasmid, seven-factor EBNA-based episomal system). 
3.7. Mycoplasma contamination testing 
Absence of mycoplasma was detected by the LookOut Mycoplasma 
PCR Detection Kit (Sigma-Aldrich – Merck) following manufacturer’s 
instructions. PCR was run on a C1000™/CFX96™ Thermal Cycler. The 
products were loaded on a 1.2% agarose gel containing HDGreen Plus 
(INTAS, Germany) and run at 100 V for 30 min. The bands were visu-
alized in the Bio-Rad ChemiDoc™ XRSC System using Image Lab™ (Bio- 
Rad, version 6.0.0). 
3.8. Genotyping analysis 
Salivary and iPSC DNA were extracted using the GeneFix™ saliva- 
Prep DNA kit (Isohelix), respectively the DNeasy® Blood & Tissue kit 
(Qiagen), and sent for genotyping with Infinium Global Screening Array 
(GSA, Illumina). The GWAS data by Demontis et al. (2019) was used to 
assess the PRS of each patient, while genomic alterations were assessed 
comparing genotypes originating from saliva to the clone’s DNA. This 
was conducted with the Genome Viewer function from the GenomeS-
tudio software (version 2.0). 
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Table 3 
Reagents details.  
Antibodies used for immunocytochemistry/flow-cytometry  





1:200 Thermo Fisher Scientific Cat# 





1:100 Thermo Fisher Scientific Cat# 





1:100 Thermo Fisher Scientific Cat# 






1:100 Thermo Fisher Scientific Cat# 







1:250 Thermo Fisher Scientific Cat# 







1:250 Thermo Fisher Scientific Cat# 







1:250 Thermo Fisher Scientific Cat# 







1:250 Thermo Fisher Scientific Cat# 
A24871, RRID: AB_2651009  
Primers  
Target Forward/Reverse primer (5′-3′) 
Pluripotency 
Markers (qPCR) 





































HMBS According to manufacturer Qiagen 249,900 
(QT00014462)  
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